Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted 4-{3-[6-amino-9-(3, 4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists

Substituted 4-{3-[6-amino-9-(3, 4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists

US Patent 8293720 · Granted Oct 23, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Devices and methods for the treatment of body surface disorders2025
Cyclic amide-containing pyridyl xanthines as A2B antagonists2025
Treatment of cutaneous disorders2025
Applicator2024
Cyclic amide-containing pyridyl xanthines as A2B antagonists2023
Treatment of cutaneous disorders2021
Applicator2020
N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonists2017
N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonists2017
Xanthine-substituted alkynyl carbamates/reverse carbamates as A2B antagonists2017
Xanthine-substituted alkynyl carbamates/reverse carbamates as A2B antagonists2017
N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonists2015